hVIVO plc Announces Interim Results Release for Six Months Ending 30 June 2026 on 15 September

hVIVO plc Announces Interim Results Release for Six Months Ending 30 June 2026 on 15 September →

hVIVO plc (AIM: HVO), the AIM-listed global frontrunner in human challenge clinical trials, has confirmed it will publish its interim results for the six months ended 30 June 2026 on Tuesday, 15 September 2026. The London-based clinical dev…